StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/304% below fair value
$29.94−0.54 (-1.76%)

Close on Nov 13, 2026Market cap $1.54BP/E –Yield 0.00%

Immunocore enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Immunocore's enterprise value was $749.14M on Nov 11, 2026, against $1.10B a year earlier. Over the last 5 years it ranged from -$315.07M to $3.07B, with a median of $769.02M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$749.14M-12.8%
2025Dec 31, 2025$859.39M+49.6%
2024Dec 31, 2024$574.47M-80.1%
2023Dec 29, 2023$2.88B–
2022Dec 30, 2022-$308.97M–

More Immunocore figures

See a number that looks wrong?